Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oasmia Pharmaceutical AB (NASDAQ:OASM)

1.02
Delayed Data
As of Nov 21
 0.00 / 0.00%
Today’s Change
0.80
Today|||52-Week Range
3.64
-63.05%
Year-to-Date
No recent news for Oasmia Pharmaceutical AB.

Today’s Trading

Previous close1.02
Today’s open0.86
Day’s range0.86 - 1.02
Volume13,508
Average volume (3 months)13,297
Market cap$176.3M
Dividend yield--
Data as of 3:11pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+1.82%
Earnings growth (this year)+58.93%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.41%
P/E ratioNM
Price/Sales4,136.78
Price/Book1.22

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...0.000.00%
BGNEBeiGene Ltd0.000.00%
TEVATeva Pharmaceutical0.000.00%
Data as of 4:00pm ET, 11/22/2017

Financials

Next reporting dateDecember 1, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.6K
Annual profit (last year)-$18.3M
Net profit margin-93,164.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Mikael Asp
Chief Financial Officer &
Executive Vice President
Anders Blom
Corporate headquarters
Uppsala, Uppsala

Forecasts